ConductScience.org, home

Paper42940211PubMed

The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research.

Bagnoli P. Biomedicines, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research. Papers, record 42940211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42940211

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research.
Journal
Biomedicines
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-28

Source PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bagnoli PPaolahttps://orcid.org/0000-0001-6659-9077

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131374938Neuroprotective Peptides in Retinal Disease.J Clin Med2019https://conductscience.org/library/papers/31374938PubMed
223434527A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots.J Pharm Biomed Anal2013https://conductscience.org/library/papers/23434527PubMed
330389750Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.Diabetes2019https://conductscience.org/library/papers/30389750PubMed
49915710Di Bella's therapy: the last word? The evidence would be stronger if the researchers had randomised their studies.BMJ1999https://conductscience.org/library/papers/9915710PubMed
541919172Mirabegron in patients with age-related macular degeneration treated for overactive bladder: a study protocol for a prospective observational non-randomized trial.Front Med (Lausanne)2026https://conductscience.org/library/papers/41919172PubMed
642688303Novel insights into β3-adrenoceptor function in a model of retinopathy of prematurity: the contribution of astrocytes to retinal protection.Front Neurosci2026https://conductscience.org/library/papers/42688303PubMed
740097526Study of the efficacy and the mechanism of action of lanreotide for the treatment of persistent diabetic macular edema.Sci Rep2025https://conductscience.org/library/papers/40097526PubMed
835986147Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1α via the PI3K/Akt/ERK pathway.Pediatr Res2023https://conductscience.org/library/papers/35986147PubMed
942459363Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.Front Neurosci2026https://conductscience.org/library/papers/42459363PubMed
1026775688Ten years of anti-vascular endothelial growth factor therapy.Nat Rev Drug Discov2016https://conductscience.org/library/papers/26775688PubMed
1123528535Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.Exp Eye Res2013https://conductscience.org/library/papers/23528535PubMed
1214614951Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina.Neuropharmacology2003https://conductscience.org/library/papers/14614951PubMed
1320739470Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.Invest Ophthalmol Vis Sci2011https://conductscience.org/library/papers/20739470PubMed
1431426601The uPAR System as a Potential Therapeutic Target in the Diseased Eye.Cells2019https://conductscience.org/library/papers/31426601PubMed
1539723681Neuropeptides: The Evergreen Jack-of-All-Trades in Neuronal Circuit Development and Regulation.Bioessays2025https://conductscience.org/library/papers/39723681PubMed
1623111729Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?Invest Ophthalmol Vis Sci2012https://conductscience.org/library/papers/23111729PubMed
1738227526On implications of somatostatin in diabetic retinopathy.Neural Regen Res2024https://conductscience.org/library/papers/38227526PubMed
1837620616Progress in Ocular Drug Delivery: Challenges and Constraints.Handb Exp Pharmacol2024https://conductscience.org/library/papers/37620616PubMed
1938847896Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.Graefes Arch Clin Exp Ophthalmol2024https://conductscience.org/library/papers/38847896PubMed
2039539264Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/39539264PubMed

See all 55 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42940211

GET https://conductscience.org/api/papers/v1/42940211/references?page=2